Taysha Gene Therapies Inc. TSHA
Super Investor & Insider
1
Fondi che lo detengono
#1301
Rank consenso
1.4%
% dei portafogli
$1.4M
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Polen Capital Management · Polen Capital Management | 0.01% | Add 104.2% | 319,748 | $1.4M |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Taysha Gene Therapies Inc. is a biotechnology company specializing in the development of transformative gene therapy treatments for central nervous system (CNS) diseases. The company is at the forefront of employing advanced gene therapy techniques to address rare, debilitating neurological conditions that lack effecti…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees99
TickerTSHA
Statistics
Market Cap$1.78B
Revenue (TTM)$9.8M
Net Income-$109.0M
Net Margin-1115.3%
EPS$-0.34
P/E2.53
P/S219.63
P/B6.59
EV/EBITDA-10.90
ROE-97.3%
Dividend Yield—
Price$6.18
Data: Twelve Data · Revenue = mcap / P/S